Another candidate chlamydia vaccine – CTH522 from Denmark's Statens ... be safe and immunogenic in early-stage healthy volunteer trials and is being prepared for additional studies to see ...

Sanofi’s chlamydia vaccine candidate was designed to protect ... vaccine will be evaluated in an upcoming phase 1/2 clinical trial (ClinicalTrials.gov Identifier: NCT06891417) that will include ...

A closely watched clinical trial testing what could be the world’s first new tuberculosis vaccine in a century has hit its ...

The chlamydia vaccine candidate has been designed to protect against primary genital tract infection and reinfection by the bacterium Chlamydia trachomatis. Chlamydia, caused by the bacterium ...

The Trump administration has reportedly disrupted over 100 clinical trials. Science News spoke to researchers about the impacts on four of them.

A study at a sexual health clinic finds that significant declines in chlamydia and syphilis were sustained nearly 2 years ...

The US Food and Drug Administration has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection. The decision was based on the potential of ...

With our programme, we aim to make chlamydia a preventable disease through vaccination.” A separate vaccine candidate has already demonstrated positive results in a randomised Phase I trial ...